Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids

Jon Andsnes Berg1 Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, NorwayCorrespondence[email protected]

Jan Schjøtt1 Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway;2 Faculty of Medicine and Dentistry, Department of Clinical Science, University of Bergen, Bergen, Norway

Kjell O Fossan1 Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway

Bettina Riedel1 Section of Clinical Pharmacology, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway;2 Faculty of Medicine and Dentistry, Department of Clinical Science, University of Bergen, Bergen, Norway

Pages 131-139 | Published online: 28 Oct 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MoodyDEMetabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphineExpert Opin Drug Metab Toxicol20139667569723537174
PubMed Web of Science ®Google Scholar
EMCDDAEuropean Drug Report 2014: Trends and Developments Available from: http://www.emcdda.europa.eu/publications/edr/trends-developments/2014Accessed April 19, 2015
Google Scholar
YokellMAZallerNDGreenTCRichJDBuprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international reviewCurr Drug Abuse Rev201141284121466501
PubMedGoogle Scholar
AtluriSSudarshanGManchikantiLAssessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011Pain Physician2014172E119E12824658483
PubMed Web of Science ®Google Scholar
BöttcherMBeckOEvaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatmentJ Anal Toxicol200529876977616356333
PubMed Web of Science ®Google Scholar
SalehAStephansonNNGranelliIVillénTBeckOEvaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci2012909613
PubMed Web of Science ®Google Scholar
GeorgeSPosition of immunological techniques in screening in clinical toxicologyClin Chem Lab Med200442111288130915576291
PubMed Web of Science ®Google Scholar
SaitmanAParkHDFitzgeraldRLFalse-positive interferences of common urine drug screen immunoassays: a reviewJ Anal Toxicol201438738739624986836
PubMed Web of Science ®Google Scholar
Thermo Fisher ScientificDrugs of Abuse Cross-Reactivity Guide, CEDIA Buprenorphine 5 ng/mL CutoffThermo Fisher Scientific, Clinical DiagnosticsFremont2013 Available from: http://www.thermoscientific.com/content/dam/tfs/SDG/CDD/CDD%20Documents/Product%20Manuals%20&%20Specifications/Diagnostic%20Testing%20Reagents/Drug%20of%20Abuse%20Testing%20(DAT)%20Calibrators%20Controls%20and%20Reagents/Drug%20of%20Abuse%20Reagents/CEDIA-Buprenorphine-5ng-mL-CRG-R14.pdfAccessed April 19, 2015
Google Scholar
MelansonSESnyderMLJarolimPFloodJGA new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuseJ Anal Toxicol201236320120622417836
PubMed Web of Science ®Google Scholar
PavlicMLibisellerKGrubwieserPRablWCross-reactivity of the CEDIA buprenorphine assay with opiates: an Austrian phenomenon?Int J Legal Med2005119637838115834736
PubMed Web of Science ®Google Scholar
HullMJBiererMFGriggsDALongWHNixonALFloodJGUrinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassayJ Anal Toxicol200832751652118713521
PubMed Web of Science ®Google Scholar
European UnionOfficial Journal of the European Communities2002 L 221/8. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:221:0008:0036:EN:PDF
Google Scholar
FerraraSDTedeschiLFrisonGDrugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniquesJ Anal Toxicol19941852782917990448
PubMed Web of Science ®Google Scholar
BirchMACouchmanLPietromartireSFalse-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpirideJ Anal Toxicol201337423323623471956
PubMed Web of Science ®Google Scholar
YueQYSvenssonJOAlmCSjöqvistFSäweJInterindividual and interethnic differences in the demethylation and glucuronidation of codeineBr J Clin Pharmacol19892866296372611085
PubMed Web of Science ®Google Scholar
PoseyBLKimbleSNHigh-performance liquid chromatographic study of codeine, norcodeine, and morphine as indicators of codeine ingestionJ Anal Toxicol19848268746716978
PubMed Web of Science ®Google Scholar
DelbekeFTDebackereMUrinary concentrations of codeine and morphine after the administration of different codeine preparations in relation to doping analysisJ Pharm Biomed Anal1991910–129599641822219
PubMed Web of Science ®Google Scholar
YueQYHasselströmJSvenssonJOSäweJPharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquineBr J Clin Pharmacol19913166356421867957
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date